Salta al menu principale di navigazione Salta al contenuto principale Salta al piè di pagina del sito

Saggi, Studi e Ricerche

N. 49 (2018)

Orientare l’organizzazione dei Servizi verso un modello efficace e sicuro di trattamento del dolore con farmaci oppiacei: l'esperienza della Casa di Reclusione di Padova

Inviata
23 ottobre 2017
Pubblicato
22-02-2018

Abstract

In carcere il dolore assume una grandezza sproporzionata e di solito non viene adeguatamente trattato. Le ragioni sono spesso dovute alla paura di prescrivere ai detenuti sostanze analgesiche oppioidi con il rischio di un uso improprio o alternativo. Lo scopo di questo studio osservazionale, condotto con 598 detenuti della Casa di Reclusione di Padova, è stato quello di identificare gli ostacoli e le barriere all’uso di farmaci analgesici oppioidi per il trattamento del dolore e trovare modalità utili per un uso razionale delle sostanze.

Riferimenti bibliografici

  1. Adams L.L., Gatchel R.J., Robinson R.C., Polatin P., Gajraj N., Deschner M., Noe C. (2004). Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. Journal of Pain and Symptom Management, 27(5): 440-59. doi: 10.1016/j.jpainsymman.2003.10.009.
  2. Alexander L., Mannion R.O., Weingarten B., Fanelli R.J., Stiles G.L. (2014). Development and impact of prescription opioid abuse deterrent formulation technologies. Drug and Alcohol Dependence, 138: 1-6. doi: 10.1016/j.drugalcdep.2014.02.006.
  3. Breivik H., Collett B., Ventafridda V., Cohen R., Gallacher D. (2006). Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. European Journal of Pain (London, England), 10(4): 287-333. doi: 10.1016/j.ejpain.2005.06.009.
  4. Chou R., Fanciullo G.J., Fine P.G., Adler J.A., Ballantyne J.C., Davies P., … Miaskowski C. (2009). Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain. Journal of Pain, 10(2). doi: 10.1016/j.jpain.2008.10.008.
  5. Croft M., Mayhew R. (2015). Prevalence of chronic non-cancer pain in a UK prison environment. British Journal of Pain, 9(2): 96-108. doi:10.1177/2049463714540895.
  6. Davis C.S., Carr D. (2016). Physician continuing education to reduce opioid misuse, abuse, and overdose: Many opportunities, few requirements. Drug and Alcohol Dependence, 163: 100-7. doi: 10.1016/j.drugalcdep.2016.04.002.
  7. Department of Health (2007). Clinical Management of Drug Dependence in the Adult Prison Setting Including Psychosocial Treatment as a Core Part.
  8. Eccleston C., Fisher E., Craig L., Duggan G.B., Rosser B.A., Keogh E. (2014). Psychological therapies (Internet-delivered) for the management of chronic pain in adults. The Cochrane Database of Systematic Reviews, (2), CD010152. doi: 10.1002/14651858.CD010152.pub2.
  9. Fazel S., Hope T., O’Donnell I., Jacoby R. (2001). Hidden psychiatric morbidity in elderly prisoners. The British Journal of Psychiatry?: The Journal of Mental Science, 179(6): 535-9. doi: 10.1192/bjp.179.6.535.
  10. Griffin M.L., McDermott K.A., McHugh R.K., Fitzmaurice G.M., Jamison R.N., Weiss R.D. (2016). Longitudinal association between pain severity and subsequent opioid use in prescription opioid dependent patients with chronic pain. Drug and Alcohol Dependence, 163: 216-221. doi: 10.1016/j.drugalcdep.2016.04.023.
  11. Levy M. (2012). Safer prescribing for prisoners. BMJ (Clinical Research Ed.), 344, e447. -- Retrieved from www.ncbi.nlm.nih.gov/pubmed/22282531.
  12. Martel M.O., Finan P.H., McHugh R.K., Issa M., Edwards R.R., Jamison R.N., Wasan A.D. (2016). Day-to-day pain symptoms are only weakly associated with opioid craving among patients with chronic pain prescribed opioid therapy. Drug and Alcohol Dependence, 162: 130-6. doi: 10.1016/j.drugalcdep.2016.02.047.
  13. NHS (2015a). Pain Management Formulary for Prisons: Implementation Guide.
  14. NHS (2015b). Pain Management Formulary for Prisons: The Formulary for acute, persistent and neuropathic pain.
  15. Public Health England (2013). Managing persistent pain in secure settings.
  16. Reid K.J., Harker J., Bala M.M., Truyers C., Kellen E., Bekkering G.E., Kleijnen J. (2011). Epidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact. Current Medical Research and Opinion, 27(2): 449-62. doi: 10.1185/03007995.2010.545813.
  17. Singleton N., Bumpstead R., O’Brien M., Lee A., Meltzer H. (1998). Psychiatric morbidity among adults living in private households, 2000. London: Office for NationalStatistics, 1-164. -- Retrieved from file:///C:/Users/hp/Downloads/psychmorb_tcm77-144477.pdf.
  18. Solanki D.R., Koyyalagunta D., Shah R.V., Silverman S.M., Manchikanti L. (2011). Monitoring opioid adherence in chronic pain patients: assessment of risk of substance misuse. Pain Physician, 14(2): E119-31. -- Retrieved from www.ncbi.nlm.nih.gov/pubmed/21412377.
  19. Turk D.C., Swanson K.S., Gatchel R.J. (n.d.). Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. The Clinical Journal of Pain, 24(6): 497-508. DOI: 10.1097/AJP.0b013e31816b1070.
  20. Wasan A.D., Butler S.F., Budman S.H., Fernandez K., Weiss R.D., Greenfield S.F., Jamison R.N. (2009). Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? The Clinical Journal of Pain, 25(3): 193-8. doi: 10.1097/AJP.0b013e318193a6c4.

Metriche

Caricamento metriche ...